About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

KEGG DRUG

DrugBank

Drug (Description in trials)

KEGG GENES

KEGG PATHWAY

Disease ID

1

[2] Albuterol; Salbutamol

[1] ADRB2 💬

[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬

[9] 12, 13, 86, 89, 113, 231, 256, 299, 340 💬

Disease ID	Name
12	Congenital myasthenic syndrome
13	Multiple sclerosis/Neuromyelitis optica
86	Pulmonary arterial hypertension
89	Lymphangioleiomyomatosis
113	Muscular dystrophy
231	Alpha-1-antitrypsin deficiency
256	Muscle glycogenosis
299	Cystic fibrosis
340	Primary ciliary dyskinesia

2

Albuterol sulfate

Name	Other Names
Albuterol sulfate	Salbutamol sulfate Accuneb Proventil Ventolin PROAIR DIGIHALER PROAIR RESPICLICK VENTOLIN HFA ALBUTEROL ALBUTEROL SULATE ALBUTEROL SULFATE HFA ALBUTEROL SULFATE INHALATION ALBUTEROL SULFATE INHALATION SOLUTION ALBUTEROL SULFATE INHALATION SOLUTION, 0.5%

💬

[2] Albuterol; Salbutamol

[1] ADRB2 💬

[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬

[9] 12, 13, 86, 89, 113, 231, 256, 299, 340 💬

Disease ID	Name
12	Congenital myasthenic syndrome
13	Multiple sclerosis/Neuromyelitis optica
86	Pulmonary arterial hypertension
89	Lymphangioleiomyomatosis
113	Muscular dystrophy
231	Alpha-1-antitrypsin deficiency
256	Muscle glycogenosis
299	Cystic fibrosis
340	Primary ciliary dyskinesia

3

Amifampridine 💬

[1] Amifampridine

[2] Amifampridine; Amifampridine Phosphate

[7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA1	potassium voltage-gated channel subfamily A member 1
KCNA2	potassium voltage-gated channel subfamily A member 2 isoform a
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNA6	potassium voltage-gated channel subfamily A member 6
KCNC3	voltage-gated potassium channel KCNC3 isoform 1
KCND2	A-type voltage-gated potassium channel KCND2
KCND3	A-type voltage-gated potassium channel KCND3 isoform 1

[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬

[3] 3, 11, 12 💬

4

Amifampridine phosphate 💬

[1] Amifampridine

[2] Amifampridine; Amifampridine Phosphate

[7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA1	potassium voltage-gated channel subfamily A member 1
KCNA2	potassium voltage-gated channel subfamily A member 2 isoform a
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNA6	potassium voltage-gated channel subfamily A member 6
KCNC3	voltage-gated potassium channel KCNC3 isoform 1
KCND2	A-type voltage-gated potassium channel KCND2
KCND3	A-type voltage-gated potassium channel KCND3 isoform 1

[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬

[3] 3, 11, 12 💬